BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3021989)

  • 1. Quantitation, with a new assay, of Theiler's virus capsid protein in the central nervous system of mice.
    Cash E; Chamorro M; Brahic M
    J Virol; 1986 Nov; 60(2):558-63. PubMed ID: 3021989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice.
    Cash E; Chamorro M; Brahic M
    Virology; 1985 Jul; 144(1):290-4. PubMed ID: 3840619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus.
    Cash E; Chamorro M; Brahic M
    J Virol; 1988 May; 62(5):1824-6. PubMed ID: 3357212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Theiler's virus with altered tropism for the central nervous system.
    Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
    J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigens to viral capsid and non-capsid proteins are present in brain tissues and antibodies in sera of Theiler's virus-infected mice.
    Cameron K; Zhang X; Seal B; Rodriguez M; Njenga MK
    J Virol Methods; 2001 Jan; 91(1):11-9. PubMed ID: 11164481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice.
    Lin X; Thiemann NR; Pease LR; Rodriguez M
    Virology; 1995 Dec; 214(1):91-9. PubMed ID: 8525642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells.
    Zurbriggen A; Fujinami RS
    J Virol; 1988 Oct; 62(10):3589-96. PubMed ID: 2843661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino acid change determines persistence of a chimeric Theiler's virus.
    Jarousse N; Grant RA; Hogle JM; Zhang L; Senkowski A; Roos RP; Michiels T; Brahic M; McAllister A
    J Virol; 1994 May; 68(5):3364-8. PubMed ID: 7512164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L; Lin X; Green TJ; Lipton HL; Luo M
    J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system.
    Jarousse N; Martinat C; Syan S; Brahic M; McAllister A
    J Virol; 1996 Nov; 70(11):8213-7. PubMed ID: 8892956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.
    Gerety SJ; Clatch RJ; Lipton HL; Goswami RG; Rundell MK; Miller SD
    J Immunol; 1991 Apr; 146(7):2401-8. PubMed ID: 1706400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.
    Zheng L; Calenoff MA; Dal Canto MC
    J Neuroimmunol; 2001 Aug; 118(2):256-67. PubMed ID: 11498260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K; Michiels T
    Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination.
    Lin X; Njenga MK; Johnson AJ; Pavelko KD; David CS; Pease LR; Rodriguez M
    J Virol; 2002 Aug; 76(15):7799-811. PubMed ID: 12097592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A; Shim B; Roos RP
    J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a specific cellular mRNA by subtractive hybridization in Theiler's virus persistent infection.
    Bureau JF; Chirinian S; Ozden S; Aubert C; Brahic M
    Microb Pathog; 1990 May; 8(5):335-41. PubMed ID: 2170807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional.
    Kang BS; Lyman MA; Kim BS
    J Virol; 2002 Jul; 76(13):6577-85. PubMed ID: 12050370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant.
    Zurbriggen A; Yamada M; Thomas C; Fujinami RS
    J Virol; 1991 Feb; 65(2):1023-30. PubMed ID: 1987366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
    McCright IJ; Tsunoda I; Libbey JE; Fujinami RS
    J Neurovirol; 2002 Apr; 8(2):100-10. PubMed ID: 11935462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.